Literature DB >> 8175885

DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1.

J Lukas1, H Müller, J Bartkova, D Spitkovsky, A A Kjerulff, P Jansen-Dürr, M Strauss, J Bartek.   

Abstract

The retinoblastoma gene product (pRB) participates in the regulation of the cell division cycle through complex formation with numerous cellular regulatory proteins including the potentially oncogenic cyclin D1. Extending the current view of the emerging functional interplay between pRB and D-type cyclins, we now report that cyclin D1 expression is positively regulated by pRB. Cyclin D1 mRNA and protein is specifically downregulated in cells expressing SV40 large T antigen, adenovirus E1A, and papillomavirus E7/E6 oncogene products and this effect requires intact RB-binding, CR2 domain of E1A. Exceptionally low expression of cyclin D1 is also seen in genetically RB-deficient cell lines, in which ectopically expressed wild-type pRB results in specific induction of this G1 cyclin. At the functional level, antibody-mediated cyclin D1 knockout experiments demonstrate that the cyclin D1 protein, normally required for G1 progression, is dispensable for passage through the cell cycle in cell lines whose pRB is inactivated through complex formation with T antigen, E1A, or E7 oncoproteins as well as in cells which have suffered loss-of-function mutations of the RB gene. The requirement for cyclin D1 function is not regained upon experimental elevation of cyclin D1 expression in cells with mutant RB, while reintroduction of wild-type RB into RB-deficient cells leads to restoration of the cyclin D1 checkpoint. These results strongly suggest that pRB serves as a major target of cyclin D1 whose cell cycle regulatory function becomes dispensable in cells lacking functional RB. Based on available data including this study, we propose a model for an autoregulatory feedback loop mechanism that regulates both the expression of the cyclin D1 gene and the activity of pRB, thereby contributing to a G1 phase checkpoint control in cycling mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8175885      PMCID: PMC2120000          DOI: 10.1083/jcb.125.3.625

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  68 in total

1.  A 60 kd cdc2-associated polypeptide complexes with the E1A proteins in adenovirus-infected cells.

Authors:  A Giordano; P Whyte; E Harlow; B R Franza; D Beach; G Draetta
Journal:  Cell       Date:  1989-09-08       Impact factor: 41.582

2.  SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family.

Authors:  J W Ludlow; J A DeCaprio; C M Huang; W H Lee; E Paucha; D M Livingston
Journal:  Cell       Date:  1989-01-13       Impact factor: 41.582

3.  C-terminal truncation of the retinoblastoma gene product leads to functional inactivation.

Authors:  J Y Shew; B T Lin; P L Chen; B Y Tseng; T L Yang-Feng; W H Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

4.  The retinoblastoma protein is phosphorylated during specific phases of the cell cycle.

Authors:  K Buchkovich; L A Duffy; E Harlow
Journal:  Cell       Date:  1989-09-22       Impact factor: 41.582

5.  The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product.

Authors:  N Dyson; P M Howley; K Münger; E Harlow
Journal:  Science       Date:  1989-02-17       Impact factor: 47.728

6.  Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells.

Authors:  J M Horowitz; S H Park; E Bogenmann; J C Cheng; D W Yandell; F J Kaye; J D Minna; T P Dryja; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

7.  Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines.

Authors:  J Lukas; M Pagano; Z Staskova; G Draetta; J Bartek
Journal:  Oncogene       Date:  1994-03       Impact factor: 9.867

8.  D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA.

Authors:  Y Xiong; H Zhang; D Beach
Journal:  Cell       Date:  1992-10-30       Impact factor: 41.582

9.  Diversity of human p53 mutants revealed by complex formation to SV40 T antigen.

Authors:  J Bártek; B Vojtĕsek; D P Lane
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

10.  Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4.

Authors:  J Kato; H Matsushime; S W Hiebert; M E Ewen; C J Sherr
Journal:  Genes Dev       Date:  1993-03       Impact factor: 11.361

View more
  74 in total

1.  Modulation of cell proliferation by cytokeratins K10 and K16.

Authors:  J M Paramio; M L Casanova; C Segrelles; S Mittnacht; E B Lane; J L Jorcano
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

2.  Human papillomavirus type 16 E7 oncoprotein binds and inactivates growth-inhibitory insulin-like growth factor binding protein 3.

Authors:  B Mannhardt; S A Weinzimer; M Wagner; M Fiedler; P Cohen; P Jansen-Dürr; W Zwerschke
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

3.  Defective DNA repair and cell cycle arrest in cells expressing Merkel cell polyomavirus T antigen.

Authors:  Stephanie K Demetriou; Katherine Ona-Vu; Erin M Sullivan; Tiffany K Dong; Shu-Wei Hsu; Dennis H Oh
Journal:  Int J Cancer       Date:  2012-05-29       Impact factor: 7.396

4.  Role of cyclins in neuronal differentiation of immortalized hippocampal cells.

Authors:  W Xiong; R Pestell; M R Rosner
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

5.  Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.

Authors:  K Alevizopoulos; J Vlach; S Hennecke; B Amati
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

6.  Merkel cell polyomavirus T antigens promote cell proliferation and inflammatory cytokine gene expression.

Authors:  Kathleen F Richards; Anna Guastafierro; Masahiro Shuda; Tuna Toptan; Patrick S Moore; Yuan Chang
Journal:  J Gen Virol       Date:  2015-12       Impact factor: 3.891

7.  The N-terminal region of the adenovirus type 5 E1A proteins can repress expression of cellular genes via two distinct but overlapping domains.

Authors:  J C Dorsman; B M Hagmeyer; J Veenstra; P Elfferich; N Nabben; A Zantema; A J van der Eb
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

Review 8.  Tailoring to RB: tumour suppressor status and therapeutic response.

Authors:  Erik S Knudsen; Karen E Knudsen
Journal:  Nat Rev Cancer       Date:  2008-09       Impact factor: 60.716

9.  Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma.

Authors:  S E Coupland; N Bechrakis; A Schüler; I Anagnostopoulos; M Hummel; N Bornfeld; H Stein
Journal:  Br J Ophthalmol       Date:  1998-08       Impact factor: 4.638

Review 10.  Cyclin D1 and human neoplasia.

Authors:  R Donnellan; R Chetty
Journal:  Mol Pathol       Date:  1998-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.